Vitamin K policies and midwifery practice: questionnaire survey
- 12 May 2001
- Vol. 322 (7295) , 1148-1152
- https://doi.org/10.1136/bmj.322.7295.1148
Abstract
Objectives: To investigate policies on neonatal vitamin K and their implementation. Design: Two phase postal survey. Setting: United Kingdom. Participants: A 10% random sample of midwives registered with the United Kingdom Central Council for nursing, midwifery, and health visiting. Of 3191 midwives in the sample, 2515 (79%) responded to phase one and 2294 (72%) completed questionnaires on their current jobs (November 1998 to May 1999). In phase two, 853 (62%) of 1383 eligible midwives gave details on 2179 of their earliest jobs (start dates before 1990). Results: All the midwives in clinical practice at the time of the survey (2271, 99%) reported that they were working in areas with official policies on neonatal vitamin K. Seven distinct policies were described: intramuscular vitamin K for all babies (1159, 51.0%); intramuscular vitamin K for babies at “high risk,” oral for others (470, 20.7%); oral vitamin K for all babies (323, 14.2%); parental choice for all (124, 5.5%); parental choice for all except babies at high risk, (119, 5.2%); intramuscular vitamin K for babies at high risk only (33, 1.5%); oral vitamin K for babies at high risk only (17, 0.7%); and a disparate group of policies including intravenous vitamin K for some babies (26, 1.1%). Previous policies were (and some may still be) open to individual interpretation and were not always followed. Conclusions: Hospital policy is not necessarily a good guide to individual practice. The primary purpose of clinical records is to document patient care, and recording practices reflect this. There is considerable variation in vitamin K policies and midwifery practice in the United Kingdom, and there is no clear consensus on which babies should receive vitamin K intramuscularly. What is already known on this topic Neonatal administration of vitamin K by the intramuscular route is effective in the prevention of haemorrhagic disease in newborn babies but has been suggested as a possible risk factor for leukaemia in children A written record confirming that vitamin K has (or has not) been given is often not found, and some research groups have attempted to impute a child's vitamin K status from hospital policy Nothing is known about how midwives interpret and implement vitamin K policies What this study adds Earlier hospital policies were open to individual interpretation and they were not always followed There is considerable variation in current vitamin K policies and midwifery practice in the United Kingdom and no clear consensus on which babies should receive vitamin K intramuscularlyKeywords
This publication has 14 references indexed in Scilit:
- Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control studyBMJ, 1998
- Childhood leukaemia and intramuscular vitamin K: findings from a case-control studyBMJ, 1996
- Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, GermanyBMJ, 1996
- Neonatal vitamin K prophylaxis in the British Isles: current practice and trendsBMJ, 1995
- Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleedingThe Lancet, 1994
- Vitamin K regimens and incidence of childhood cancer in DenmarkBMJ, 1994
- The Risk of Childhood Cancer after Neonatal Exposure to Vitamin KNew England Journal of Medicine, 1993
- Administration of vitamin K to newborn infants and childhood cancer.BMJ, 1993
- Childhood cancer, intramuscular vitamin K, and pethidine given during labour.BMJ, 1992
- Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.BMJ, 1991